1
|
Graves A, Hessamodini H, Wong G and Lim
WH: Metastatic renal cell carcinoma: Update on epidemiology,
genetics, and therapeutic modalities. Immunotargets Ther. 2:73–90.
2013.PubMed/NCBI
|
2
|
Szychot E, Apps J and Pritchard-Jones K:
Wilms' tumor: Biology, diagnosis and treatment. Transl Pediatr.
3:12–24. 2014.PubMed/NCBI
|
3
|
Silberstein J, Grabowski J, Saltzstein SL
and Kane CJ: Renal cell carcinoma in the pediatric population:
Results from the California Cancer Registry. Pediatr Blood Cancer.
52:237–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
González-Sánchez A, Jaraíz-Rodríguez M,
Domínguez-Prieto M, Herrero-González S, Medina JM and Tabernero A:
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in
glioma cells and astrocytes. Oncotarget. 7:49819–49833. 2016.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Davis NM, Sokolosky M, Stadelman K, Abrams
SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro
A, et al: Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in
breast cancer: Possibilities for therapeutic intervention.
Oncotarget. 5:4603–4650. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Luo X, Liao R, Hanley KL, Zhu HH, Malo KN,
Hernandez C, Wei X, Varki NM, Alderson N, Chu C, et al: Dual shp2
and pten deficiencies promote non-alcoholic steatohepatitis and
genesis of liver tumor-initiating cells. Cell Rep. 17:2979–2993.
2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gao F, Huang W, Zhang Y, Tang S, Zheng L,
Ma F, Wang Y, Tang H and Li X: Hes1 promotes cell proliferation and
migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human
colon cancer. Oncotarget. 6:38667–38680. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kwak MK, Johnson DT, Zhu C, Lee SH, Ye DW,
Luong R and Sun Z: Conditional deletion of the Pten gene in the
mouse prostate induces prostatic intraepithelial neoplasms at early
ages but a slow progression to prostate tumors. PLoS One.
8:e534762013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang J, Qiu Y, Shi NW, Zhao JN, Wang YC,
Jiang H and Qian HB: microRNA-21 mediates the TGF-β1-induced
migration of keratinocytes via targeting PTEN. Eur Rev Med
Pharmacol Sci. 20:3748–3759. 2016.PubMed/NCBI
|
10
|
Qi Y, Liu J, Saadat S, Tian X, Han Y, Fong
GH, Pandolfi PP, Lee LY and Li S: PTEN induces apoptosis and
cavitation via HIF-2-dependent Bnip3 upregulation during epithelial
lumen formation. Cell Death Differ. 22:875–884. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Stumpf M and den Hertog J: Differential
requirement for pten lipid and protein phosphatase activity during
zebrafish embryonic development. PLoS One. 11:e01485082016.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Stumpf M, Blokzijl-Franke S and den Hertog
J: Fine-tuning of pten localization and phosphatase activity is
essential for zebrafish angiogenesis. PLoS One. 11:e01547712016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 225:402–408. 2001.
View Article : Google Scholar
|
14
|
Ragos V, Fotiades PP, Tsiambas E and
Peschos D: PTEN in laryngeal carcinomas. J BUON. 21:1024–1025.
2016.PubMed/NCBI
|
15
|
Heymont J, Berenfeld L, Collins J,
Kaganovich A, Maynes B, Moulin A, Ratskovskaya I, Poon PP, Johnston
GC, Kamenetsky M, et al: TEP1, the yeast homolog of the human tumor
suppressor gene PTEN/MMAC1/TEP1, is linked to the
phosphatidylinositol pathway and plays a role in the developmental
process of sporulation. Proc Natl Acad Sci USA. 97:12672–12677.
2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lu XX, Cao LY, Chen X, Xiao J, Zou Y and
Chen Q: PTEN inhibits cell proliferation, promotes cell apoptosis,
and induces cell cycle arrest via downregulating the PI3K/AKT/hTERT
pathway in lung adenocarcinoma a549 cells. BioMed Res Int.
2016:24768422016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wu KL, Wu CA, Wu CW, Chan SH, Chang AY and
Chan JY: Redox-sensitive oxidation and phosphorylation of PTEN
contribute to enhanced activation of PI3K/Akt signaling in rostral
ventrolateral medulla and neurogenic hypertension in spontaneously
hypertensive rats. Antioxid Redox Signal. 18:36–50. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Shojaee S, Chan LN, Buchner M, Cazzaniga
V, Cosgun KN, Geng H, Qiu YH, von Minden MD, Ernst T, Hochhaus A,
et al: PTEN opposes negative selection and enables oncogenic
trans-formation of pre-B cells. Nat Med. 22:379–387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang L, Yu Q, He J and Zha X: Study of
the PTEN gene expression and FAK phosphorylation in human
hepatocarcinoma tissues and cell lines. Mol Cell Biochem.
262:25–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gupta A and Dey CS: PTEN, a widely known
negative regulator of insulin/PI3K signaling, positively regulates
neuronal insulin resistance. Mol Biol Cell. 23:3882–3898. 2012.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Gerisch G, Schroth-Diez B,
Müller-Taubenberger A and Ecke M: PIP3 waves and PTEN dynamics in
the emergence of cell polarity. Biophys J. 103:1170–1178. 2012.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Ebbesen SH, Scaltriti M, Bialucha CU,
Morse N, Kastenhuber ER, Wen HY, Dow LE, Baselga J and Lowe SW:
Pten loss promotes MAPK pathway dependency in HER2/neu breast
carcinomas. Proc Natl Acad Sci USA. 113:3030–3035. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li J, Yin LL, Su KL, Zhang GF and Wang J:
Concomitant depletion of PTEN and p27 and overexpression of cyclin
D1 may predict a worse prognosis for patients with post-operative
stage II and III colorectal cancer. Oncol Lett. 8:1543–1550. 2014.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Qu W, Fu JD, Yang F, Yang GL, Zhang YL,
Wang XY, Gu HX, Zhang HY and Wang L: Clinical implications of PTEN
andVEGF expression status, as well as microvessel density
inesophageal squamous cell carcinoma. Oncol Lett. 10:1409–1415.
2015. View Article : Google Scholar : PubMed/NCBI
|